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The painful answer seems to be "all of them." Reliability matters. Safety matters.
Efficiency matters. Patient experience matters. All of these dimensions of performance are intertwined, and interact to define the quality of an institution's care.
Life was simpler when the major metric by which institutions judged their success was financial performance. In truth, these varied quality metrics are much better reflections of what truly defines success for health care organizations, so their complexity should not be viewed as unsolvable problem. Indeed, they are already driving improvement in outcomes --but there are some difficult steps to be taken before performance improvement moves into a "higher gear."
In this issue of Circulation, Mehta et al., set the stage for the work ahead by revealing the interactions among two dimensions of quality --the reliability with which clinicians delivered evidence-based interventions and the safety with which they delivered it 4 . They used data from the national quality improvement initiative, CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines) and analyzed the relationship between clinical outcomes and measures of both guideline adherence and safety.
In this 39,291 patient population, median adherence to ACC/AHA guidelinerecommended therapies was not perfect, but high (85%), while dosages of antithrombotic agents that were considered in safe ranges were given just 53% of the time. In aggregate, the hospitals that were above average on guideline adherence were above average on every one of the acute and discharge treatment measures (see Table 2 of paper). Similarly, the hospitals that were below average on safety were more likely to use excessive doses of both heparin and glycoprotein IIb/IIIa inhibitors. Nevertheless, the world was not divided into "good" and "bad"
performers. As shown in Figure 1 of the paper, there was only a loose correlation between nteractions among two dimensions of quality --the reliability with which clinic cia ia ans ns s d d del el eliv iv iver er ere ed ed evidence-based interventions and the safety with which they delivered it 4 . They used data from h he e na na nati ti tion on nal al alua ali li lity ty ty improvement initiative, CRU U USA SA ADE (Can Rap p pid i R Ris is isk k k Stratification of U Uns s sta t ble Angi gina na a P P Pat tie ie ient nt ts s S S Sup up upp pr pres es ss s AD AD ADv v verse e e O O Outc c co om me es s w wit it th E Ear ar rly ly y I Imp mp ple e eme me ent nt tat atio io on n n of of of t the he e AC AC CC/ C/ C/AH AH A A A A Gu Gu G id id del l lin ines es) an and an an a al al alyz yz yzed e ed t t the he e r r rel el elat t tio io ion ns sh hi hip p b bet et etw we ween en en c cl li l ni ni nica ca c l l l ou ou utc tcom om omes es a a an nd nd m m me ea easu su ure res s s o both guideline ne e a a adh dh her er eren en nce c c a a and nd nd saf af afet et e y. y. y. In short, both guideline adherence and safety mattered. There were striking declines in the risk for in-hospital mortality for every 10% improvement in adherence or in safety. The hospitals with above average performance on both had an adjusted 17% reduction in their risk adjusted mortality odds ratio, compared to hospitals that were below average on both. Hospitals that were high on one and low on the other had intermediate risk adjusted mortality rates. Use of safe medication doses also correlated with lower rates of bleeding events.
The data have face validity. Safety and adherence to guidelines both strongly influence mortality, even in a study population that is substantial but not enormous in size. As the authors so aptly note in their title and Introduction, it is important to do the right thing, and it is important to do them right -and one cannot automatically assume both are happening. There are errors of omission, and errors of commission -and both worsen patient outcomes.
What these findings imply for performance improvement is that it is time to re-integrate the various streams of quality that emerged after the IOM reports --reliability in guidelines adherence, safety, patient experience, and efficiency. Even more important, it is time to redefine performance in terms of what we are actually trying to accomplish in health care. We cannot assume that a hospital that is excellent on guideline compliance metrics is also excellent in patient safety. All of these dimensions of quality are separate, yet intertwined, and they combine to determine the outcomes and costs of care. No one is likely to be "the best" on all of them. We have to measure them all, and try to improve them all -and we have to measure and try to improve their ultimate results.
The first major point that emerges from this logic train is that we have to measure actual patient outcomes. Clinicians have been leery of putting too much attention on patient outcomes o aptly note in their title and Introduction, it is important to do the right thing, a an nd nd i it t is is is mportant to do them right -and one cannot automatically assume both are happening. There are er rro ro ors rs rs o o of f f om om omis is i sion on on, , a and errors of commission -an an and d both worsen pa pa p tien en nt t t o o outcomes.
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It is crucial that institutions understand when they are statistically worse than expected on Tier 1 outcomes, such as mortality. That should precipitate an all-hands-on-deck effort to dissect whether patient selection, poor guideline adherence, or suboptimal safety are causing the gap.
On the other hand, organizations cannot expect to "pull away from the crowd" on the basis of the hardest Tier 1 outcomes such as mortality, because survival rates tend to be clustered at high The third point that emerges from this logic train is that new methods are needed to motivate clinicians to care about these outcomes and process metrics 6 . The challenge of engaging hard-working clinicians in improvement of how they work together is complicated by the relentless demands they already face in their work day. That said, if physicians in particular are mportant 5 . But, he argues, Tier 2 outcomes related to the process (e.g., readmiss sio i ions n n , th th the e e disutility of care) matter as well, as do Tier 3 outcomes, which reflect the durability of health n nte te erv rv rven en enti ti tion on ons (e.g .g g., ., t the likelihood of a patient ne e ee ed edi in ng a repeat pro ro oce c du du ure re re.) .
It is cr ruc ucia i i l l l th th ha a at i i ins ns st ti titu tu tut ti tion on ns s s u u un nd de e ersta an and d d wh h he en n the he hey y a a are e e st sta a ati is sti tica cally y y w wo wor rs rse e th th than an n e exp xp pec ecte te t d d d on
Ti Tier er er 1 1 1 o o out utco co com me mes s, s, s suc uch h h as as s m mor or rta tali li lit t ty. y. y. Th Th hat at at s s sh ho houl ul uld d d p pr pre ec e ip ip ipit it tat at ate e e an an an a a all l ---ha ha hand nd ds-s--on on n-d -d -ec ec e k k k ef ef effo for r rt t t to o d di diss s sec e whether pati ien en nt t se se ele le lect ctio io ion, n p p poo oo oor gu gu guid id del e e in n ne e ad ad adhe he here re renc nc nce, e, e, o or su su subo bo bopt pt ptim im imal al s s saf af afet et ety y y ar ar are e ca ca caus us usin in ing g g the gap.
not engaged in the process of improvement, much of the data collection for quality improvement pointless. Progress on clinician engagement takes thoughtful use of incentives, both financial and non-financial, all as part of the pursuit of a shared purpose that is widely embraced by the health care organization's providers.
As clinicians organize to take on the overarching task of improving their outcomes, they should note one other finding from Mehta, et al. In this report, the institutions with both low adherence and low safety were more likely to be smaller hospitals that were less likely to have capabilities for revascularization, and with patients less likely to be treated by a cardiologist.
This finding supports concentrating volumes of patients where there is sufficient scale to justify a real team expert in meeting their needs. Consolidation of care is painful because it inevitably means deciding not to deliver it everywhere. Patients may have to travel a half hour further, but the improvement in outcomes will likely offset the delay.
In summary, to take performance in health care to a higher level, the time has arrived to bring together the disparate measurement streams related to quality, and recognize that our work is nothing less than being reliably excellent in all of them. Health care is complex, and there are no two or three most important functions that define excellence. Therefore, we must be willing to measure actual patient outcomes, and work relentlessly to improve them. The question that providers should ask when they look at these outcomes data is not who is the best, but how can we get better than we currently are. And, as they strive to do so, they should then turn to the many types of quality-related data that collectively influence the value of their care.
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